Cardinal health reports first quarter fiscal year 2025 results and raises fiscal year 2025 outlook

Revenue decreased 4% to $52.3 billion; revenue increased 15% excluding the impact of the previously communicated large customer contract expiration gaap 1 operating earnings were $568 million; gaap diluted eps was $1.70 non-gaap operating earnings increased 12% to $625 million, driven by significant growth in pharmaceutical and specialty solutions segment profit non-gaap diluted eps increased 9% to $1.88 fiscal year 2025 non-gaap eps guidance2 raised to $7.75 to $7.90, from $7.55 to $7.70 dublin, ohio , nov. 1, 2024 /prnewswire/ -- cardinal health (nyse: cah) today reported first quarter fiscal year 2025 revenue of $52.3 billion, a decrease of 4% from the first quarter of fiscal year 2024. first quarter revenue increased 15% excluding the impact of the previously communicated large customer contract expiration.
CAH Ratings Summary
CAH Quant Ranking